Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
Efficacy of Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
To evaluate efficacy of vitrectomy with inverted internal limiting membrane (ILM) flap technique for macular hole retinal detachment (MHRD) in highly myopic eyes, and to demonstrate postoperative clinical course of MHRD after inverted ILM flap technique using swept-source optical coherence tomography (OCT)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 7, 2016
CompletedFirst Posted
Study publicly available on registry
September 12, 2016
CompletedJanuary 10, 2017
January 1, 2017
3.9 years
September 7, 2016
January 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity before and after surgery
Changes from baseline to 1, 3, 6 months
Secondary Outcomes (1)
Optical coherence tomography
Changes from baseline up to 6 months
Study Arms (2)
Inverted ILM flap group
ACTIVE COMPARATOREyes underwent vitrectomy with inverted internal limiting membrane technique
ILM peeling group
ACTIVE COMPARATOREyes underwent vitrectomy with internal limiting membrane peeling
Interventions
Vitrectomy with inverted ILM technique or ILM peeling
Eligibility Criteria
You may not qualify if:
- The patients with follow-up less than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Makoto Inoue, MD
Kyorin Eye Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Ophthalmology
Study Record Dates
First Submitted
September 7, 2016
First Posted
September 12, 2016
Study Start
April 1, 2012
Primary Completion
March 1, 2016
Study Completion
September 1, 2016
Last Updated
January 10, 2017
Record last verified: 2017-01